# Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants

> **NCT00169442** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 745 (actual)

## Conditions studied

- Whole Cell Pertussis
- Diphtheria
- Hepatitis B
- Tetanus
- Haemophilus Influenzae Type b

## Interventions

- **BIOLOGICAL:** Tritanrix™-HepB/Hiberix™ Kft.
- **BIOLOGICAL:** Tritanrix™-HepB/Hiberix™
- **BIOLOGICAL:** Hiberix™
- **BIOLOGICAL:** Polyribosil-Ribitol-Phosphate (PRP) vaccine
- **BIOLOGICAL:** Tritanrix™-HepB Kft

## Key facts

- **NCT ID:** NCT00169442
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02-10
- **Primary completion:** 2006-03-01
- **Final completion:** 2006-03-10
- **Target enrollment:** 745 (ACTUAL)
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00169442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00169442, "Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00169442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*